H. Boucher

Infectious Diseases · 2006–2013

A researcher in the Science corpus: 5 papers; trusts 1 researcher and is trusted by 1 researcher here, as inferred from the citation graph.

Subfields

Whom H. Boucher trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. L. Rice
  2. Henry F. Chambers
  3. B. Spellberg
  4. R. Gordon

Who trusts H. Boucher overall

  1. Neil O. Fishman
  2. M. Huemer
  3. Emily R. M. Sydnor
  4. Richard J. Fair
  5. Gerard D. Wright

Papers from H. Boucher's perspective

Ordered by how strongly the researchers H. Boucher trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. (Clinical Infectious Diseases)
  2. Linezolid resistance in a clinical isolate of Staphylococcus aureus. (The Lancet)
  3. Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern
  4. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. (Clinical Infectious Diseases)
  5. Genome and virulence determinants of high virulence community-acquired MRSA.
  6. Methicillin-resistant S. aureus infections among patients in the emergency department. (New England Journal of Medicine)
  7. Antibiotic resistance among gram-negative bacilli in US intensive care units: implications for fluoroquinolone use. (Journal of the American Medical Association (JAMA))
  8. Global Challenge of Multidrug-Resistant Acinetobacter baumannii (Antimicrobial Agents and Chemotherapy)
  9. Clinical and Economic Impact of Common Multidrug-Resistant Gram-Negative Bacilli (Antimicrobial Agents and Chemotherapy)
  10. Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE. (Journal of Infectious Diseases)

Their papers